Promotions & Moves

Curt Pagano Joins Delavau Pharmaceutical Partners

Named new VP of quality and regulatory

Delavau Pharmaceutical Partners, a contract manufacturer of over-the-counter (OTC) pharmaceuticals and vitamin-mineral supplements (VMS), has appointed industry veteran Curt Pagano to its team as the vice president of quality and regulatory.

“We provide our customers everything from product development to finished goods, so maintaining high quality standards is imperative,” said John Burrows, president and chief executive officer, Delavau Pharmaceutical Partners. “Curt’s extensive knowledge and experience in the pharmaceutical space will be a great asset to our business and our customers.”

Mr. Pagano’s career in quality engineering and regulation began at Warner-Lambert (later acquired by Pfizer). In addition to his 30 years of experience managing quality assurance functions, compliance systems and audits, Mr. Pagano is certified in Six Sigma and Lean philosophies. He initiated the methodologies at Pfizer and other companies, leading to operational efficiency gains.

“The addition of Curt to our team is part of our ongoing commitment to offer our customers the highest quality vitamins, minerals, supplements, and over-the-counter products,” said Jay Jones, general manager, Delavau Pharmaceutical Partners. “As we continue to grow, Curt will be essential to furthering the high standards we’ve set for ourselves in all areas of our business.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters